Upcoming Programs

January 28, 2015
Guest: Dr. Melissa Price, VP of Clinical and Regulatory Affairs, Heat Biologics,Inc., Durham
Topic: Heat Biologics, a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) adjuvant technology for use in a number of oncology and infectious disease indications

TBD
Guest: Dr. Stewart Witzeman, Director, Eastman Innovation Center, North Carolina State University
Topics: Eastman Innovation Center, public/private partnerships, fostering innovation in materials and design

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s